12 Aug, 2026 1:44 PM (IST)
Novelix Pharmaceuticals Performance
- Today's Low
- ₹73
- Today's High
- ₹79
- 52 Week Low
- ₹38
- 52 Week High
- ₹92
- Open Price₹79
- Previous Close₹77
- Volume1,247
- 50 DMA₹69.60
- 100 DMA₹65.90
- 200 DMA₹59.20
Novelix Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 14.96%
- Over 3 Month + 39.35%
- Over 6 Month + 22.16%
- Over 1 Year + 91.6%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 52.7
- PEG Ratio
- 0
- Market Cap Cr
- 135
- P/B Ratio
- 3.1
- Average True Range
- 4.5
- EPS
- 1.5
- Dividend Yield
- 0
- MACD Signal
- 0.7
- RSI
- 59.73
- MFI
- 57.99
Latest Stock News Updates
Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior Intimation of Board meeting.
- BSE India
- 2 days 19 hours ago
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
- BSE India
- 3 weeks 6 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandrasekhar Reddy & Others
- BSE India
- 4 weeks 1 day ago
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹71.40
- 50 Day
- ₹69.60
- 100 Day
- ₹65.90
- 200 Day
- ₹59.20
Resistance and Support
- R3 83.50
- R2 80.30
- R1 78.50
- S1 73.50
- S2 70.30
- S3 68.50
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-13 | Quarterly Results | |
| 2026-06-04 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Approve the Draft Notice of EGM. 2.Fix the day, date, time & venue of EGM. 3. Appoint Scrutinizer for conducting E- voting process for EGM. 4. Other business matters. |
| 2026-05-29 | Audited Results & Preferential issue | |
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results |
About Novelix Pharmaceuticals
Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities. View More- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Popular Stocks
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹76 As on 12 August, 2026 | 14:03
The Market Cap of Novelix Pharmaceuticals is ₹134.7 Cr As on 12 August, 2026 | 14:03
The P/E ratio of Novelix Pharmaceuticals is 52.7 As on 12 August, 2026 | 14:03
The PB ratio of Novelix Pharmaceuticals is 3.1 As on 12 August, 2026 | 14:03
The 52 week High & Low of Novelix Pharmaceuticals is ₹92/₹38 respectively As on 12 August, 2026 | 14:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.